A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern › Research Explorer

DOI

https://doi.org/10.1016/j.xcrm.2021.100486
Final published version

Original language	English
Article number	100486
Journal	Cell Reports Medicine
Volume	3
Issue number	1
Early online date	2022
DOIs	https://doi.org/10.1016/j.xcrm.2021.100486
Publication status	Published - 18 Jan 2022

Research areas

BNT162b2, COVID-19, SARS-CoV-2, antibody response, mRNA vaccine, neutralization, previous infection, response predictors, variants

ID: 21060458